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This overview of the prevalence of Metabolic Syndrome (MetS) in Iran considers the reports on regional
and ethnic variation, international comparisons, and within speciﬁc groups, including children, diabetics
and women at different stages of their life-course. The reported impact of lifestyle is also discussed. One
particular controversy has been the deﬁnition of MetS, and this remains a difﬁculty across ethic groups
and in children and adolescents. The changes in the criteria being applied to determine the presence of
MetS, also makes trends in prevalence difﬁcult to interpret.
© 2018 KeAi Communications Co., Ltd. Publishing Services by Elsevier B.V. on behalf of KeAi
Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The prevalence of MetS varies with the criteria used to deﬁne it,
and with demographic factors such as age, gender, ethnicity and
socioeconomic status. Iran is ethnically,1 geographically and
climatically2 a highly diverse country, with a total population of
approximately 80 million people. The interpretation of epidemio-
logical data, on its changing prevalence in Iran must therefore take
this into account. The numerous studies attempting to estimate the
prevalence of MetS in different age groups and regions of Iran (see
Table 1) are difﬁcult to compare directly, as different criteria for
MetS have been applied, the age ranges of those recruited do not
fully align, and different sampling strategies have been used.
Furthermore, if there have been temporal changes in the preva-
lence of MetS as suggested by some longitudinal studies, the
prevalence rates may not be directly comparable. However, the
prevalence of MetS in some regions within Iran is amongst the
highest reported globally.nications Co., Ltd.
vier on behalf of KeAi
lishing Services by Elsevier B.V. on
es/by-nc-nd/4.0/).
, Ghayour-Mobarhan M, Meta
sr.2018.04.0012. The reported general prevalence of metabolic syndrome in
adults
2.1. In northern Iran
One of the ﬁrst cohort studies to determine the prevalence of
MetS in a deﬁned urbanised region in Iranwas the Tehran Lipid and
Glucose Study (TLGS),3 in which the MetS was deﬁned by the
presence of three or more of the following components: abdominal
obesity, hypertriglyceridemia, low high density lipoprotein-
cholesterol (HDL-C), high blood pressure (BP), and high fasting
blood glucose (FBG). The age-standardized prevalence was re-
ported as 33.7%.and increased with age in both sexes, but was
signiﬁcantly more common in women than in men (42% vs. 24%).
More recently (2009) in an urban population of 2941 adults > 20
years old from Zanjan province, located to the west of Tehran, MetS
was deﬁned using National Cholesterol Education Program, Adult
Treatment Panel-III (ATP-III) criteria4 and was present in 23.7% of
subjects (23.1% of men and 24.4% of women).5
The prevalence of MetS and its association with body mass in-
dex (BMI), socio-demography, and lifestyle habits was investigated
in a random sample of 984 women aged 30e50 years old living in
Babol in 2009. ATPIII criteria were used to deﬁne MetS and its
overall prevalence was 31.0%. Abdominal obesity was found in
about 76.6% (n ¼ 273) of subjects. Older age, higher waist circum-
ference (WC), higher systolic (SBP) and diastolic (DBP) bloodbehalf of KeAi Communications Co., Ltd. This is an open access article under the CC
bolic syndrome in Iran: A review, Translational Metabolic Syndrome
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ATPIII National Cholesterol Education Programme, Adult
Treatment Panel-III
CMetSys Continuous Metabolic Syndrome risk score
DASH Dietary approaches to stop hypertension
GDM Gestational diabetes mellitus
HDL-C High density lipoprotein-cholesterol
HOMA Homeostasis model assessment
IDF-AHA/NHLBI International Diabetes Federation-American
Heart Association/National Heart Lung and
Blood Institute
IDF International Federation of Diabetes
IFG Impaired fasting glucose
IGT Impaired glucose tolerance
IHHP Isfahan Healthy Heart Program
IR Insulin-resistant
IS Insulin-sensitive
JIS Joint Interim Societies
KERCADRS Kerman Coronary Artery Disease Risk Study
LDL-C Low density lipoprotein-cholesterol
MetS Metabolic Syndrome
NAFLD Non-alcoholic fatty liver disease
NHANES National Health and Nutrition Examination Survey
PCOS Polycystic ovary syndrome
QUICKI Quantitative insulin check index
ROC Receiver operating characteristic
SuRNCD Survey of risk factors of non-communicable diseases
TLGS Tehran Lipid and Glucose Study
WHR Waist-to-Hip Ratio
Table 1
Studies of the prevalence of metabolic syndrome in adults in Iran.
Date Region n Age (y) Criteria Prevalence (%) Total Male (%) Female (%) Urban (%) Rural (%)
20033 Tehran 10,368 >20 33.7 24 42
200412 Three centres 12,514 >19 ATPIII 23.3 10.7 35.1 24.2 19.5
200722 Multi-centre 3024 25e64 37.4
20095 Western 2941 >18 ATPIII 23.7 23.1 24.4
20096 Northern Iran 984 30e50 ATPIII e 31.0
2007
2011109
National survey e 25e64 IDF 35.95
32.96
201229 North East 1194 >18 ATPIII 29.1 31.1 55.0
























201414 Central 8313 >18 ATPIII 21.9
201518 Southern Iran 377 >20 ATPIII 26.8 16.6 36.8













2015113 North East Iran 9829 35e65 ATPIII 38.8
201690 South West Iran 12,283 20e65 WHO 38.9 36 41.5
20168 Northern Iran 1562 >18 Local criteria 74.3
20167 Northern Iran 5910 40e64 ATPIII 10.9 13.0
201728 Northern Iran 248 25e70 ATPIII 37.6
2005
2017112
Central Iran 2000 20e74 ATPIII 44.8
ATPIII¼National Cholesterol Education Programme, Adult Treatment Panel-III; IDF¼ International Diabetes Federation; AHA¼ American Heart Association; NHLBI¼National
Heart Lung and Blood Institute; NHANES ¼ National Health and Nutrition Examination Survey; WHO ¼World Health Organization.
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were associated with increased risk for MetS.6
In 2016, the Shahroud eye cohort study sample comprised of
5190 middle aged individuals (40e64 years) from east of Tehran,
was used to assess the prevalence of MetS. This was related to age
and gender. The prevalence of MetS was 10.9% in men, 13.0% in
women and 12.1% in total. The prevalence increasedwith age. Using
multivariate logistic regression analysis, educational attainment
and positive smoking habit, had signiﬁcant effects on the risk of
MetS.7
The prevalence of MetS and its components was determined in
an elderly population from Amirkola in 2016, using four differentPlease cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Met
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001diagnostic criteria.8 The study was part of the larger community-
based Amirkola Health and Ageing Project (AHAP)9 study, and
comprised 1562 individuals (55.2% male). Applying an Iranian
deﬁnition of MetS, 1160 persons (74.3%) had MetS, higher than for
the other three deﬁnitions. The highest prevalence was observed in
females in the age group of 65e74 and the lowest in males in the
age group of 85e99 years old.
Amol is near the Caspian Sea, whilst Zahedan is in the southeast,
near the border with Pakistan. In 2014, the prevalence of MetS was
determined according to two deﬁnitions and compared the char-
acteristics of the subjects who met the MetS criteria according to
the different deﬁnitions. Participants were recruited from familyabolic syndrome in Iran: A review, Translational Metabolic Syndrome
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both the ATPIII and International Diabetes Federation (IDF)
criteria.10 Using this approach, 3 groups could be identiﬁed: 1) In-
dividuals without MetS, based on either deﬁnition, 2) Individuals
with MetS according to one of the deﬁnitions, and 3) Individuals
who met both ATPIII and IDF criteria for MetS. Subjects from Amol
(n ¼ 5826) and Zahedan (n ¼ 2243) were enrolled into the study.
The weighted prevalence of MetS according to the ATPIII and IDF
criteria was 27.8% and 26.9% in Amol and 12% and 11.8% in Zahedan,
respectively. Overall, 18.9% of the subjects fulﬁlled the criteria for
both deﬁnitions of MetS, whilst 8.5% met the MetS criteria ac-
cording to one deﬁnition only.11
2.2. In central Iran
The Isfahan Healthy Heart Program (IHHP) assessed the preva-
lence of the MetS using ATP III criteria in 12,514 adults (19 years)
living in urban and rural areas in and around 3 cities in central Iran.
The age-adjusted prevalence of MetS was 23.3%, with a higher
prevalence in women compared to men (35.1% vs. 10.7%, P < 0.05)
and in urban residents compared to rural residents (24.2% vs. 19.5%,
P < 0.05).12
The use of the continuous MetSy risk score (CMetSyS)13 has
been recommended to deﬁne MetS. In 2014 the CMetSyS was
applied to data from the baseline survey of the IHHP. The study
population consisted of 8313 individuals (49.9% male, with a mean
age 38.54 ± 15.86 years). MetS was found in 21.86% of the popu-
lation. Triglycerides and WC were the best predictive components.
The CMetSySwas signiﬁcantly associatedwith serum high sensitive
C-reactive protein (Hs-CRP), BMI, leisure time, and workplace
physical activity as well as age and gender.14
2.3. In southern Iran
The Kerman Coronary Artery Disease Risk Study (KERCADRS) is
a cohort study of 6000 individuals resident in Kerman city.15 Esti-
mates of the prevalence of the different components and deﬁni-
tions of MetS were investigated. Using IDF criteria, the prevalence
of MetS was 25.2% in men and 42.5% in women; the corresponding
values were 31.0% in men and 38.0% in women using ATPIII criteria.
The prevalence of MetS increasedwith age in both genders, peaking
at the age of 51e60 years in both.
The prevalence of the MetS as well as cut-off points for WC for
the diagnosis of MetS was investigated in 1802 people (735 men
and 1067 women) aged19 years from Zahedan in 2012. MetS was
deﬁned using ATP III, and the IDF criteria and WC cut-off points for
IDF criteria. The prevalence of MetS according to ATP III, IDF and IDF
-AHA/NHLBI were 21.0% (15.4% in men and 24.9% in women), 24.8
(20.0% in men, 28.1% in women) and 23.3% (19.7% in men, 25.8% in
women), respectively.16
The prevalence of MetS and its components was determined in a
cross-sectional study of a rural population living in Kavar. The
population comprised 13,304 adults aged >20 years (32.6% male).
MetS was deﬁned using ATP III criteria and its prevalence was
compared to the rates estimated by modiﬁed ATPIII and IDF deﬁ-
nitions. The prevalence of ATP III-deﬁned-MetS was 25.1%
compared to 27.7% and 28.3% using the modiﬁed ATP III and IDF
deﬁnitions, respectively. The prevalence rate was higher among the
females compared to the males by all the deﬁnitions (28.4% in fe-
males and 18.9% in males by ATP III criteria, P < 0.001) and
increased with age (P < 0.001).17
Between October 2012 and April 2013, 377 adults aged 20
years (190 women and 187 men with a mean age of 43.8 ± 11.0
years) were invited to a Petroleum Industry Health Organization
Polyclinic, in Shiraz. MetS was deﬁned using the revised ATPIIIPlease cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Meta
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001criteria, and 101 individuals were found to have MetS; 16.6% of men
and 36.8% of women (P < 0.001). The prevalence increased by
almost 15% with each decade of life (P < 0.001).18
The association between MetS andmenopausal status in Iranian
women was investigated in 490 pre- and 434 postmenopausal
women from the Shiraz Women's Health Cohort Study. MetS was
deﬁned according to ATPIII and IDF criteria. Postmenopausal
women had a modestly higher prevalence of MetS (60.2% versus
59.4%, respectively). WC, waist-to-hip ratio (WHR), blood pressure,
and levels of fasting plasma glucose (FPG), total cholesterol, low
density lipoprotein cholesterol (LDL-C), and triglycerides were
higher in postmenopausal women compared to premenopausal
women.19
2.4. In western Iran
The prevalence and characteristics of MetS amongst women of
reproductive agewas investigated in a cross-sectional study using a
systematic randomized sampling method. In 406 women of
reproductive age living in Abhar City, the prevalence rate of MetS
was 28.1%. This ﬁgure increased with age and BMI. The majority of
cases with MetS were either overweight or obese (53.5%). The
greatest rise in prevalence of MetS was observed in the age range
between 45 and 49 years (70.6%).20 Amongst 100 postmenopausal
women, who were referred to the health centers in Gorgan, MetS
was only marginally higher at 31%, using ATP III criteria.21
2.5. National surveys of the prevalence of metabolic syndrome
The ﬁrst national estimate on the prevalence of the MetS and its
components in Iranians aged between 25 and 64 year old, living in
urban and rural areas of all 30 provinces in Iran was undertaken in
2009. Several criteria were used for the deﬁnition of the MetS and
its age-standardized prevalence was approximately 34.7% (95% Cl
33.1e36.2) based on the ATPIII criteria. Its prevalence was higher in
women, and in those living in urban areas.22
A systematic review of all available studies on MetS in the adult
Iranian population, estimated the overall prevalence of MetS in
2015 was 36.9% (95% CI: 32.7e41.2%) based on the ATPIII criteria,
34.6% (95% Cl: 31.7e37.6%) according to the IDF, and 41.5% (95% Cl:
29.8e53.2%) based on the Joint Interim Societies (JIS) criteria.23 The
prevalence of MetS determined by JIS was signiﬁcantly higher than
for values determined by ATP Ill and IDF. The prevalence of MetS
was 15.4% lower in men than in women (27.7% versus 43.1%) based
on the ATP III criteria, and it was 11.3% lower in men based on the
IDF criteria; however according to the JIS criteria, it was 8.4% more
prevalent in men.24
A further systematic review regarding MetS and its risk factors
among Iranian adults aged >19 years during 2005e2014 was also
published in 2015. From the 43 studies, the rate of MetS varied from
10% to 60% depending on sex, age and region. The highest rate re-
ported was among postmenopausal women in Shiraz, and was over
60%. The rate of MetS was higher among women compared with
men across all, apart from a single study. A particularly high gender
difference (43.3% vs. 17.1%) was observed in western Iran (Korde-
stan province). MetS was signiﬁcantly more prevalent among older
adults, postmenopausal women, less-educated people, those living
in urban areas and those with low physical activity and unhealthy
eating habits.25
Whilst these national statistics are not directly comparable,
there are some interesting conclusions that can nevertheless be
drawn. The prevalence of MetS increases with age; in Iran, like
many other Asian and Middle Eastern countries, MetS is more
prevalent in women26; and the criteria used in the west are not
appropriate for the Iranian population. There appear to be markedbolic syndrome in Iran: A review, Translational Metabolic Syndrome
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populations. What is less clear is whether the overall prevalence
has increased signiﬁcantly since 2003, despite the reported in-
crease in prevalence of obesity.27
3. Ethnic and international comparisons
The impact of age in the prediction of the non-adiposity related
components of MetS, and to determine the optimal cut-off values
for the prediction of MetS, was investigated in Turkman and non-
Turkman residents of northern Iran. Subjects who were 25e70
years age (n ¼ 248) were recruited, and MetS deﬁned using ATP-III
criteria. The prevalence of MetS was 37.6% and was 14.7% higher in
non-Turkman than in Turkman individuals, respectively. Mean FBG,
triglycerides, WC and diastolic blood pressure (DBP) were also
signiﬁcantly higher in the non-Turkman group.28
The prevalence of MetS and its components were compared
between an adult population from Mashhad in north-eastern Iran
(n ¼ 1194) and a population from north-eastern France (n ¼ 1386).
MetS was deﬁned by ATP III criteria. The prevalence of MetS was
signiﬁcantly higher in Iranian women (55.0%), followed by Iranian
men (30.1%), French men (13.7%) and French women (6.6%). Ira-
nian women had high rates of abdominal obesity (65.0%), hyper-
tension (52.1%), hypertriglyceridemia (43.1%), and low high-
density lipoprotein cholesterol (HDL-C; 92.7%). Iranian men had
high rates of hypertension (48.9%), hypertriglyceridemia (42.8%),
and low HDL-C (81.8%). French men had high rates of hyperten-
sion (44.7%) and moderate rates of hypertriglyceridemia (28.6%)
and hyperglycemia (23.9%). There was a relationship between
waist circumference and the lipid components of MetS in both
countries.29
The harmonised paediatric deﬁnition of the MetS deﬁned by the
IDF30 has allowed a global comparison of the prevalence. The
prevalence of MetS and its components was assessed in two large
representative samples of adolescents in Germany and Iran, Data
from 3647 German adolescents aged 10e15 years old participating
in the German PEP Family Heart Study31 and 2728 Iranians in the
same age range participating in the CASPIAN Study were compared.
MetS was four times more prevalent in Iranian (2.1%) compared to
German (0.5%) adolescents.32
These ethnic and international data are striking and important
for several reasons. The obvious conclusion is that there are sub-
stantial differences in the prevalence of MetS between ethic and
national groups, irrespective of the criteria used to deﬁne it. This is
consistent with studies in other countries.33 These appear to
emerge early in adolescence. The sexual dimorphism of the
phenotype appears to occur in late adolescence, but differs be-
tween populations in Iran and the West.34
4. The prevalence of metabolic syndrome in deﬁned groups
4.1. Impact of physical activity
Two approaches to this question have been adopted: using a
questionnaire to determine the extent of physical activity, and by
assessing the prevalence of MetS in speciﬁc occupational groups
with different levels of physical activity.
The association between different aspects of physical activity
and MetS was investigated in a nationally representative sample of
3296 Iranian adults as part of the third national survey of risk
factors of non-communicable diseases (SuRFNCD-2007). Physical
activity was evaluated with respect to 3 domains: work,
commuting, and recreational activities. Both duration and intensity
of activity were assessed. MetS was deﬁned using the IDF and the
ATPIII criteria. The national prevalence of MetS was estimated to bePlease cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Met
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001between 24% and 30%, depending on sex and the criteria used. The
prevalence of MetS increased incrementally among individuals
with high-, moderate-, and low-category activity was 18.7 ± 1.5%,
25.8 ± 2.0%, and 27.9 ± 2.0%, respectively (P < 0.001). These rates
were 12.6 ± 1.6%, 26.0 ± 1.5%, and 34.1 ± 3.2% among individuals
with vigorous activity, with non-vigorous activity, and without
activity, respectively (P < 0.001). The risk for MetS increased 1.28-
fold with every 30-min/d reduction in vigorouseintensity activity
(P < 0.001).35
A cross-sectional study evaluated the prevalence of MetS among
1488 ofﬁce workers in Qom province in Central Iran, by using a
multi-stage cluster sampling. MetS was deﬁned based on blood
HDL-cholesterol, triglyceride, and FBG levels and waist circumfer-
ence, and blood pressure. Its prevalencewas 35.9% overall, higher in
men (37.2%) than in women (20.6%), and increased with age.36
The prevalence of MetS has also been investigated in 234 Iranian
male seafarers working for the National Iranian Tanker Company
(NITC) in 2015. MetS was diagnosed according to the reports of
National Committee of Obesity. The mean age of the participants
was 36.0 ± 10.3 years. The prevalence of MetS was 14.9%.37
Among 429 bus and truck drivers from Kashan, and using the
ATPIII criteria, the prevalence of MetS was 35.9%. Hypertension,
diabetes, overweight and obesity were seen in 42.9%, 7%, 41% and
23% of the drivers, respectively.38 Among 12,138 long distance
drivers, resident in West Azerbaijan province, 3697 subjects were
found to have MetS, using IDF criteria. The crude and age-adjusted
rates of MetS were 30.5% and 32.4% respectively. 5027 subjects
(41.4%) were overweight (BMI  25.01e30 kg/m2), and 2592
(21.3%) were obese (BMI  30.01 kg/m2).39
These data are consistent with an increasing risk of MetS and
obesity being associated with low levels of physical activity.
4.2. Association with impaired glucose tolerance and diabetes
mellitus
The prevalence of MetS was determined using two established
criteria for ATPIII and IDF and a new deﬁnition for MetS, from a
population sample of 950 diabetic type 2 patients in Kerman in
central Iran. The prevalence of MetS in this sample was 73.4, 64.9,
and 70.4%, respectively.40
A similar study in Type 2 diabetics fromGorgan, in northern Iran
used ATP-III criteria, and reported a prevalence of MetS in this
group was 51.50%, with a higher prevalence in women.41
Gestational diabetes mellitus (GDM) affects nearly 5% of preg-
nancies and women with a history of GDM have a higher risk of
type 2 diabetes mellitus (T2DM).42 The incidence of abnormal
blood glucose level andMetS was investigated in 110womenwith a
history of GDM who had delivered during 2004e2010 in three
hospitals of Zanjan City. The patients were recalled to perform an
oral glucose tolerance test and other tests required for a diagnosis
of MetS. Of the 110 women, 36 (32.7%) developed T2DM and 11
(10%) had impaired fasting glucose (IFG) or impaired glucose
tolerance (IGT). 22 women (20%) had developed MetS.43
MetS is highly prevalent in type 2 diabetics and is a strong risk
factor for cardiovascular diseases in these patients.44
4.3. Association with polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is characterized by ovarian
dysfunction, hyperandrogenism and PCO morphology by ultra-
sound.45 Its clinical manifestations may also include obesity, insulin
resistance (IR) and an increased risk of type 2 diabetes and car-
diovascular events.46
The prevalence of MetS was investigated in 215 women from
Rasht in northern Iran with PCOS (deﬁned by the Rotterdam 2003abolic syndrome in Iran: A review, Translational Metabolic Syndrome
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2012. The prevalence of MetS in women with PCOS was 28.8%,
higher than reported by other studies in Iranian women with
PCOS.48 The prevalence of MetS has also been assessed among
Iranian women diagnosed within different phenotypic subgroups
of PCOS based on the Rotterdam criteria.49 The study recruited
women with PCOS who were referred to infertility clinics, and was
conducted between January 2006 and June 2008, in Isfahan. The
subjects underwent metabolic screening according to ATP III
guidelines and IR screening was based on the homeostasis model
assessment (HOMA) of insulin resistance. The prevalence of MetS
and IR were 24.9% and 24.3%, respectively. A signiﬁcant difference
in the prevalence of MetS was reported for anovulatory women
with PCOS with or without hyperandrogenism (23.1% and 13.9%,
respectively; P ¼ 0.001).
The frequency of IR was compared between 136 individuals
with PCOS and 423 healthy controls. PCOS and MetS were diag-
nosed using the Rotterdam 2003 criteria and JIS, respectively. IR
was deﬁned using the (HOMA-IR). In this population sample, MetS
was no more frequent in a representative sample of Iranianwomen
with PCOS than in healthy controls. However, the prevalence of IR
in PCOS was higher than in controls.50
The presence of IR and MetS were assessed in 63 overweight or
obese PCOS patients subdivided into insulin-resistant (IR) and
insulin-sensitive (IS) groups. Fasting insulin concentration and
HOMA-IR were higher (P < 0.001), and quantitative insulin check
index (QUICKI), glucose-to-insulin ratio (P < 0.001), and HDL-C
(P ¼ 0.012) were lower in the IR group. MetS (P ¼ 0.034) and
obesity (P ¼ 0.038) were more prevalent in IR group.51
PCOS is therefore associated with metabolic abnormalities that
are also components of MetS. It is unclear whether it would be
clinically effective to screen all women with PCOS for MetS and IR,
as their prevalencemay vary by PCOS phenotype, ethnicity and age.4.4. Association with hypertension
The prevalence of the MetS and its different features were
compared among hypertensive and normotensive subjects, derived
from a representative sample of adults living in 3 cities in Iran.
Among the 12,514 subjects, selected by multi-stage random sam-
pling, 13.9% were hypertensive. The prevalence of the MetS, using
the ATPIII criteria, was signiﬁcantly higher in hypertensive than
normotensive subjects (51.6% versus 12.9%, respectively). The
prevalence of MetS was also greater in normotensive and hyper-
tensive subjects living in urban areas than those living in rural areas
(14.2% and 53.9% versus 9.5% and 45.6%, respectively, P < 0.05). A
combination of hypertension with MetS was more prevalent in
women than men (72% versus 28% respectively, P < 0.000), and in
subjects living in urban areas than those in rural areas (75.1% versus
24.9%), respectively.524.5. The impact of diet
In a cross-sectional study using a representative sample of
Isfahani female nurses, a dietary score was used for assessing
compliancewith a DASH diet and this was related to the presence of
MetS deﬁned according to the Joint Scientiﬁc Statement criteria.
Individuals in the highest tertile of the DASH diet score53 had 81%
lower odds of MetS than those in the lowest category (OR 0.19; 95%
CI 0.07e0.96). Participants with the greater adherence to the DASH
diet were less likely to have enlarged waist circumference, hyper-
glyceridemia, low HDL-C levels, and high blood pressure, respec-
tively. Adherence to the DASH eating plan was inversely associatedPlease cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Meta
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001with the odds of MetS and most of its features among a group of
Iranian women.54
The relationship between dietary intake and MetS was investi-
gated in 984 middle-aged (30e50 years) women from the urban
area of Babol, in northern, Iran. Dietary patterns were evaluated
using a food frequency questionnaire. The ATP III criteria were used
to deﬁne MetS. A good dietary pattern, rich in fruits, legumes,
vegetables, cereals, and ﬁsh, as well as high intake of dairy products
and eggs decrease the likelihood of MetS. The adjusted OR for MetS
in womenwith low fat intake was higher than in womenwith high
and moderate fat (OR ¼ 2.92; 95%, CI ¼ 1.36, 6.28).55
The relationship between the presence of MetS and compliance
with a Mediterranean diet was investigated in 158 patients with
T2DM, aged 28e75 years old. Food frequency questionnaires
comprised an 11-item score to determine the adherence to a
Mediterranean diet; 55.4% of participants had good adherence to
Mediterranean diet. The presence of MetS in women was signiﬁ-
cantly higher than in men (P < 0.001). Nuts, legumes and seeds
consumption were associated with a signiﬁcant lower risk of MetS
(P < 0.05), but no association was observed between MetS and
adherence to a Mediterranean diet.56
The beneﬁcial effects of a Mediterranean diet57 and DASH type
diets58 on the features of MetS have been established; these data
from Iran are consistent with these western studies.
5. The prevalence of metabolic syndrome in children and
adolescents
MetS in children and adolescents is becoming a global public
health concern because it tracks into adulthood59 and is then
associated with an increased risk for type 2 diabetes mellitus and
cardiovascular disease.60
A national study was conducted among 4811 students (2248
boys and 2563 girls) aged 6e18 y, living in six different provinces in
Iran, recruited to determine the prevalence of paediatric MetS and
its best predictive anthropometric index. Two deﬁnitions for MetS
were used: type A, based on criteria analogous to ATP III; type Bwas
deﬁned according to the cut-offs obtained from NHANES III. Both
types A and B deﬁne high FBG as>100mg/dL and SBP/DBP as >90th
percentile. Themean age of students was 12.07 ± 3.2 y. Type AMetS
was seven times more prevalent than type B MetS (14% vs 2%,
respectively, P < 0.0001), and there was no signiﬁcant gender dif-
ference. Waist circumference (WC) and waist-to-hip ratio (WHR)
had the strongest and weakest associations, respectively, with the
MetS.61 The impact of environmental factors on the prevalence of
MetS among young people is limited. The association of these
factors with MetS was also investigated in this sample of Iranian
children; MetS was detected in 14.1% of participants. A birth weight
of >4000 g in boys and <2500 g in girls increased the risk of having
theMetS. Poorly educated parents and a positive parental history of
chronic disease were other risks factors associated with MetS. Low
levels of physical activity signiﬁcantly increased the risk of having
MetS. The risk of MetS increased with the consumption of solid
hydrogenated fat and bread made with white ﬂour. However, an
increased frequency of consumption of fruits and vegetable, as well
as dairy products decreased the risk of having MetS.62
Another nationally representative sample (recruited from 23
provinces in Iran) of 5738 adolescents (2875 girls) aged from 10 to
18 years (mean 14.7 ± 2.4 years) and obtained as part of the third
study of the school-based surveillance system entitled CASPIAN III.,
was used to study the prevalence of different components of MetS,
and their discriminative value was assessed using receiver oper-
ating characteristic (ROC) curve analysis; 17.4% of participants were
underweight and 17.7% were overweight or obese. Using IDFbolic syndrome in Iran: A review, Translational Metabolic Syndrome
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risk factor, 8.0% had two, 2.1% had three, and 0.3% had all the four
components of MetS. The prevalence of MetS was 15.4% in the
overweight/obese participants, the corresponding ﬁgure was 1.8%
for the normal-weight students, and was 2.5% in the whole popu-
lation studied.63
The relationship between MetS, using ATP III criteria, and its
individual components were related to socio-economic factors
obtained using a self-administered questionnaire amongst 538
14e18 year-old adolescents living in Shiraz. Approximately 6% of
the adolescents had MetS, with signiﬁcantly more males than fe-
males (9.3% vs 2.4%, P < 0.001) being affected, an unusual ﬁnding
for an Iranian population. Therewere positive associations between
the components of MetS and parental education, school location
and household monthly income.64 The CASPIAN III study has
recently reported that increasing socioeconomic status was asso-
ciated with an increased risk of MetS.65
The prevalence of MetS and IR was determined in 338 children
and adolescents (172 girls) aged 10e18 years old from Qazvin, in
northern Iran. They were selected using a multistage cluster
random sampling technique. MetS was deﬁned according to the IDF
criteria. IR was estimated by the homeostatic model assessment.
The overall prevalence of MetS and IR were 3.4% and 18.2%,
respectively.66
A representative sample of 1425 Iranian elementary school
children from Birjand was used to assess the best preventive
measures for MetS in this age group. They were recruited through
multiple-cluster sampling in 2013. MetS was deﬁned according to
ATP-III criteria based on the National Cholesterol Education Pro-
gram. The overall prevalence of MetS was 5.3% and increased with
age. 43.5% of children had one or more components of the MetS.
The prevalence of MetS was 0.9% in normal weight, 11.3% in over-
weight and 36.2% in obese children.67
The prevalence of the MetS, and its component factors was
determined among 622 high school girls (15e17 years old) living in
Mashhad, Iran. A self-administered questionnaire was used to
assess socio-demographic characteristics and dietary habits.
Anthropometric assessments, blood pressure measurement and
biochemical assessment were done. Applying BMI Z-score for age
and gender (WHO 2007), 14.6% and 3.4% of subjects were classiﬁed
as overweight and obese, respectively. A large WC (>80 cm) was
found in 9.5% of the girls. Based on ATP III criteria, the overall
prevalence of the MetS was 6.5% and increased to 45.1% in obese
subjects. A high socioeconomic status of the family, and a high
consumption of carbohydrates were inﬂuencing factors in the
prevalence of MetS.68
The prevalence of MetS and the association between MetS and
obesity was investigated in a population of 450 adolescents from
northern Iran. High school students (50% boys), aged 15e18 years,
were enrolled in the study. MetS was deﬁned using modiﬁedTable 2
Studies of the prevalence of metabolic syndrome in children in Iran.
Date Region n Age (y) Criteria Prev




200968 North East Iran 622 15e17 ATPIII
200970 Central Iran 1221 10e15 ATPIII
201032 Multi-centre 2728 10e15 IDF 2.1
201269 Northern Iran 450 15e18 NHANES-III 3.3
201363 Multicentre 5738 10e18 IDF 2.5
201567 East Iran 1425 6e10 ATPIII 5.3
201566 North West Iran 338 10e18 IDF 3.4
201664 Southern Iran 538 14e18 ATPIII 6
ATPIII¼National Cholesterol Education Programme, Adult Treatment Panel-III; IDF¼ Inte
Heart Lung and Blood Institute; NHANES ¼ National Health and Nutrition Examination S
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3.3%. The associations between a BMI 85th percentile and MetS,
and between a BMI 75th percentile and MetS were statistically
signiﬁcant. The association between an increased WC and MetS
was also statistically signiﬁcant, conﬁrming the high prevalence of
components of MetS among apparently healthy Iranian adoles-
cents, even among those who were not overweight.69
The prevalence of obesity and MetS was investigated in 1221
adolescent girls (mean age 14.3 ± 1.7 years) living in Rafsanjan.
MetS was deﬁned using ATPIII criteria; 11.2% and 2.4% of subjects
were overweight and obese respectively; 3.9% had MetS.70
In a systematically review of the prevalence of MetS among
Iranian children and adolescents. aged 3e21-year-old. The preva-
lence range of MetS among children was 1e22% using the different
deﬁnitions. The reported range of MetS deﬁned by different criteria
was as follows: ATP III; 3e16%, IDF; 0e8%, AHA; 4e9.5%, The
NHANES III; 1e18%, de Ferranti; 0e22%. MetS is a common meta-
bolic disorder among Iranian children and adolescents, with
increasing trends during the last decades71 (see Table 2).
6. Metabolic syndrome and its associated conditions
The differences between patients with and without coronary
artery disease (CAD), regarding the presence of MetS and its com-
ponents, and selected lifestyle behaviours, including dietary intake,
physical activity patterns, and smoking habits was investigated, in
an attempt to determine whether MetS was an independent risk
factor for CAD. The study used a caseecontrol methodology for the
collection and analysis of the data. Six hundred participants were
recruited. MetS was associated with a 4.19-fold increased risk of
CAD (P ¼ 0.0001). However, multivariate analysis showed that
MetS did not add any additional predictive information beyond its
components.72
The prevalence of MetS was investigated in a group of 100
healthy children and adolescents (6e16 years old, 58% female) with
a bodymass index (BMI) above the 85th percentile for their age and
sex in Qazvin Province in northern Iran. Two deﬁnitions of MetS
were compared: the ATP III criteria and a modiﬁed deﬁnition by
Weiss et al.73 The mean BMI of the group was 26.02 ± 4.38 and 80%
had obesity. IR was found in 81% of the study population. MetS was
present in 50% of the overweight and 66.2% of the obese subjects by
applying ATP III criteria. MetS was present in 25% of the overweight
and 42.5% of the obese subjects using the deﬁnition of Weiss et al.
There were no statistically signiﬁcant differences between the two
groups with MetS deﬁned with MetS by the two criteria.74
The relationship between physical activity and MetS was
investigated in a large national-representative sample of chil-
dren.75 School students (2248 boys and 2563 girls) aged 6e18
years, were recruited between 2003 and 4 using multi-stage




rnational Diabetes Federation; AHA¼ American Heart Association; NHLBI¼National
urvey; WHO ¼World Health Organization.
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deﬁned using ATPIII criteria. In all age groups, boys were more
physically active than girls. The MetS was detected in 14.1% of
participants, and its prevalence was higher in those subjects with
the lowest levels of physical activity. In both genders, before and
after adjustment for age and bodymass index, low levels of physical
activity signiﬁcantly increased the risk of having the MetS [in boys:
OR: 1.8, (CI: 1.1e2.1); and in girls, OR: 1.6 (CI 1.1e1.9)].7. The prevalence of the components of the metabolic
syndrome
The prevalence and distribution of cardiovascular risk factors
and MetS in 4811 nationally representative children and adoles-
cents aged 6e18 years with generalized, central, or combined types
of obesity were investigated to determine if a phenotypically obese
metabolically normal and a metabolically obese normal weight
phenotype could be identiﬁed. Children were recruited through
randomly selected schools within six provinces in Iran. Varying
with age and gender, 6e9% of children had isolated central obesity,
7.5e11% had isolated generalized obesity, and 14e16.5% had com-
bined obesity. The prevalence of dyslipidemia, high blood pressure,
and MetS was higher in those children with combined obesity than
in those with the other two types of obesity.76 The most prevalent
CVD risk factors in this population sample were a low HDL-C (28%),
followed by hypertriglyceridemia (20.1%), and overweight (17%).
ROC analyses showed that in boys, who were in the 10e13.9 and
14e18-year-age groups, respectively, waist circumference (WC) and
body mass index (BMI) were best for distinguishing CVD risk fac-
tors. Amongst girls, these indices were respectively BMI and waist
to stature ratio (WSR); WC and WSR; and WC.77
The prevalence of obesity, central obesity and WHR obesity in
individuals between 15 and 70 years old were determined in in-
dividuals who were chosen randomly from 23 clusters in Golestan
province in northern Iran in 2013; and a comparison made by
ethnic group (Turkman ¼ 166, and non-Turkman ¼ 298). In-
dividuals with a BMI (BodyMass Index) of <25, 25.0e29.9, 30e39.9
and 40 kg/m2 were classiﬁed as normal, overweight, obese and
pathologic obese. Central obesity was deﬁned by waist circumfer-
ence of WC > 102 cm in men and >88 cm in women. WHR (Waist-
to-Hip Ratio)0.95 cm and0.8 cmwere classiﬁed asWHRobesity
for men and women, respectively. General obesity and overweight
were seen in 30.0% and 28.2% of subjects, respectively. For the non-
Turkman group, obesity was signiﬁcantly more common in women
(men ¼ 19.4% and women ¼ 43.9%; P ¼ 0.001) whereas it was not
signiﬁcantly different in the Turkman group (men ¼ 16.4% vs
women ¼ 30.0%). Central obesity was also very common (40.7%)
with a signiﬁcant difference between genders (men ¼ 22.9% vs
women ¼ 54.4%) (P ¼ 0.001). Compared to Turkman men and
women, the prevalence of central obesity was 12% and 19.2% and
was more common in the non-Turkman group (P ¼ 0.003). In the
whole population sample, WHR obesity was common in 62.7% and
63.1% of men and women, respectively. Hence, general obesity,
central obesity and WHR obesity are common in northern Iran and
more common in non-Turkman than in the Turkman group.78 This
work was extended to investigate the prevalence of central obesity
in the three predominant ethnic groups among 2993 individuals
(Fars-native ¼ 1627, Turkaman ¼ 974 and Sisstani ¼ 392) aged
15e65 years and living in urban and rural areas within 11 districts
in Golestan province in northern Iran. The groups werematched for
age and sex. Central obesity was deﬁned using WHO criteria. The
mean WC in the three ethnic groups were: Fars, 88.88 ± 15.83 cm,
Turkman, 89.11 ± 14.12 cm and Sisstani, 84.41 ± 13.74 cm. Central
obesity was found in 36.9%, 34.9% and 27.6% of each ethnic group,Please cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Meta
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001respectively (P ¼ 0.002) and was more common in women (54.5%)
than men (15.7%). (P ¼ 0.001).79
The third national Surveillance of Risk Factors of Non-
Communicable Diseases (SuRFNCD-2007), investigated 5287 Ira-
nian citizens, aged 15e64 years. Data were collected on de-
mographics, diet, physical activity, smoking, history of
hypertension, and history of diabetes. Anthropometric character-
istics were measured and serum biochemistry proﬁles were
determined on venous blood samples The prevalence of diabetes,
hypertension, obesity, and central obesity were 8.7%, 26.6%, 22.3%,
and, respectively. The prevalence of hypertriglyceridemia was
36.4%. These rates were higher among females (except hyper-
triglyceridemia) and urban residents.80 The trends of overweight
and obesity among Iranian adults (25e64 years old) within an 8-
year period (1999e2007) were assessed using datasets of three
cross-sectional national surveys: The National Health Survey-1999
(n ¼ 21,576), National SuRFNCD-2005 (n ¼ 70,945), and SuRFNCD-
2007 (n ¼ 4186). The overall prevalence of obesity increased from
13.6% in 1999 to 19.6% in 2005 and 22.3% in 2007(P < 0.001). . The
corresponding values for overweight subjects were, 32.2%, 35.8%
and 36.3%, respectively (P < 0.001). The increase in prevalence of
obesity was seen in both males and females, and both urban and
rural residents.81
A systematic review of studies on the prevalence of overweight
and obesity in the Iranian paediatric population from January 1990
to the end of December 2013 has shown a large variation for the
reported values in different age and sex groups had large varia-
tions; from 1 to 16.1% and from 4.4 to 42.3% respectively for obesity
and overweight.82
In a meta-analysis of 107 studies, the overall prevalence of
obesity and overweight remained relatively constant in the 2000s
in children and adolescents at about 5.1% and 10.8%, respectively. A
meta-regression analysis showed that the prevalence of obesity
and overweight did not vary signiﬁcantly with respect to sex and
age of study participants. Girls had a lower prevalence of obesity
and higher prevalence of overweight than boys. Although the
prevalence of childhood obesity in Iranian children was not very
high, there is an escalating trend of excess weight among young
children.83
The trends in the national prevalence of overweight and obesity
amongst 6 year old children were compared for the northern,
central and southern parts of Iran in 2011. The data were collected
as part of a routine and mandatory national screening program on
children entering elementary schools in 2007, 2008 and 2009. Data
were available for 2,600,065 children. Among all the children 12.8%,
13.5% and 10.9% were overweight in 2007, 2008 and 2009,
respectively. The corresponding ﬁgures for obesity were 3.4%, 3.5%
and 3.4%, respectively. For all three surveys, the prevalence of
overweight and obesity was highest in the southern region, but was
constant over the three years. It was suggested that the higher
prevalence of overweight in the southern region may be related to
the lower socioeconomic status of this population.84
The latter hypothesis is consistent with data from Rasht; in
which the prevalence and predictors of overweight and obesity by
location of residence was assessed amongst randomly selected
2577 urban school girls aged 12e17 years. Data on age, frequency of
skipping breakfast per week, physical activity, hours of television
viewing, self-perception about body condition, and home address
were collected. Data on birth-weight of the girls, educational
attainment of parents, weights and heights of parents, and
employment status of mothers were obtained from parents using a
self-administrated questionnaire. The overall prevalence of over-
weight and obesity was 18.6% and 5.9% respectively. Overweight or
obesity was more common among girls from low-income areas
compared to high-income areas (21.6% vs 17.1%, P < 0.001).bolic syndrome in Iran: A review, Translational Metabolic Syndrome
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the girls, as was overweight or obesity in a parent.85 However, the
data of Motlagh et al.84 are odds with another cross-sectional
nation-wide study.86 In this study, 14,880 school students aged
6e18 years, were selected using a multistage random cluster
sampling from 30 provinces in Iran. TheWorld Health Organization
growth curve was used to categorize Body Mass Index (BMI).
Obesity was deﬁned as a BMI equal to or greater than the age-and
gender-speciﬁc 95th percentile; abdominal obesity was considered
as waist-to-height ratio 0.5. 13,486 students completed the study
(6543 girls and 75.6% urban residents), with a mean age of 12.45
years. The prevalence rate of general and abdominal obesity was
11.89% (13.58% of boys vs. 10.15% of girls) and 19.12% (20.41% of boys
vs. 17.79% of girls), respectively. The highest frequency of obesity
was found in the middle school students. The Southern and South
Eastern provinces had the lowest prevalence of general obesity
(2.6% and 5.6%) and abdominal obesity (7.4% and 8.8%). The highest
prevalence of obesity was found in north and north west Iranwith a
frequency of 18.3% general obesity and 30.2% of abdominal obesity.
Furthermore, another nationwide survey also challenges the
association with a low socioeconomic status.87 In a representative
sample of 5528 students aged 10e18 years from 27 provinces of
Iran, a potential model of the relationship between various cardio-
metabolic risk factors including obesity, unhealthy diet, low phys-
ical activity, dyslipidemia, and high blood pressure. The mean age
of study participants was 14.7 ± 2.41 years and themean bodymass
index (BMI) was 19.4 ± 4.1. In this study a higher socioeconomic
status was associated with an unhealthy diet, low physical activity
and high BMI in both sexes. Age was directly related to low physical
activity in both sexes. BMI was positively related to total choles-
terol, triglyceride, low-density lipoprotein cholesterol, and mean
arterial pressure.
The prevalence of obesity and its association with hypertension
was assessed in a sample of 2000 children and adolescents aged
11e17 years, from Shiraz, who were recruited from 2010 to 11.
Approximately 7% and 11.8% of the students were obese and hy-
pertensive, respectively. Obesity was found to be an important risk
factor for hypertension. The prevalence of obesity had not changed
over the previous 5 years, but that of hypertension had risen
signiﬁcantly.88
Reference percentile curves are often used to assess growth
disorders in children. These may differ according to ethnicity and
lifestyle patterns. A comparison was made between the curves of
anthropometric measures obtained in two national studies of Ira-
nian children and adolescents (10e18-years-old) collected between
2003e2004 and 2009e2010. Age-and gender-speciﬁc percentiles
were determined and themodel was smoothed. Comparison of two
series of studies showed that the weight, BMI, WC, and waist-to-
height ratio were lower in adolescent girls than boys especially in
the higher percentiles. In both genders, weight, BMI, and WC per-
centiles had fallen.89
8. Deﬁning regional reference ranges
8.1. Adiposity
8.1.1. Measures of adiposity in adults
The optimal cut-off values for waist circumference in Turkman
and non-Turkman people in the northern Iran was determined
using a representative sample of 248 subjects aged 25e70 years,
from 25 clusters. ATP-III criteria were used for MetS. There were
signiﬁcant differences between Turkman and non-Turkman groups
in almost all the parameters used to deﬁne MetS: HDL-C, low
density lipoprotein-cholesterol (LDL-C), cholesterol, triglycerides
(TG), and FBG. The cut-off values of WC for hyper TG, low HDL-CPlease cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Met
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001and diabetes were 6.0, 7.25 and 8.25 cm higher in the non-
Turkman group than in Turkman group.72
A study was conducted to determine the best discriminators for
the diagnosis of the MetS among six obesity indexes, and the
optimal cut-off values for all obesity indexes were determined,
using data from 5910 subjects from the Haraz cohort study in
northern Iran. The discriminatory power of six obesity indexes,
including, body mass index (BMI), waist circumference (WC), waist
to hip ratio (WHR), waist to height ratio (WHtR), abdominal volume
index (AVI) and conicity index (CI) were compared for the diagnosis
of at least two other components of MetS. The Youden index was
used to determine the optimal cut-off values. The optimal cut-off
points in men were 26.0 kg/m2 for BMI, 90 cm for WC, 0.90 for
WHR, 0.53 for WHtR, 16.6 (cm2) for AVI and 1.24(m3/2/kg1/2) for CI.
The optimal values in women were 29.0 kg/m2 for BMI, 91 cm for
WC, 0.86 for WHR, 0.58 for WHtR, 17.0(cm2) for AVI and 1.23 (m3/2/
kg1/2) for CI. The prevalence of overweight or obesity was 46.1%e
54.1% in women and 49.5%e53.6% in men based on various obesity
indexes. The area under the ROC curves (AUCs) varied from
0.671(0.651e0.690) for CI to 0.718(0.700e0.736) forWC inmen and
from 0.668 (0.646e0.690) for BMI to 0.755(0.735e0.774) for WHR
and CI in women.73
Several criteria have been proposed to deﬁne abdominal obesity.
The prevalence of overweight and obesity was estimated using
different criteria in 844 female teachers living in Yazd city, in
central Iran, in 2015. Anthropometric, demographic data and life-
style factors were collected using a self-reported questionnaire. The
prevalence of general overweight and obesity were 44.5% and
27.5%, respectively using BMI cut-offs. The prevalence of abdominal
obesity based on WC measurements was 42.2% based on Iranian
national criteria. The prevalence of abdominal obesity using WHR
data, ranged from 23% based on criteria developed for Omani
women to 93.5% based on Iranian criteria. The WHtR, prevalence of
abdominal adiposity ranged between 83.5 and 92.9% based on two
different suggested criteria for Iranian females. Applying the Ira-
nian criteria gave the highest number of signiﬁcant associations for
abdominal obesity based on WC and WHR; however this was not
the case for WHtR.74
Central obesity is commonly assessed using gender- and
ethnicity-speciﬁc waist circumference (RC) cut-off values, the WC
cut-offs by the IDF developed for European populations, may not be
appropriate for Iranian populations. The optimal cut-off points for
the diagnosis of MetS in Iranwere evaluated in a population of 2752
adults (1046 men). Subjects with two or more of the following risk
factors from the IDF criteria were considered as having multiple
risk factors: hyperglycemia (FBG  100 mg/dL or diagnosed dia-
betes), high blood pressure (SBP  130 mmHg, DBP  85 mmHg, or
using antihypertensive drugs), lowHDL (<50mg/dL for females and
<40 mg/dL for males), and high TG (>150 mg/dL). The WC cut-off
with the highest sensitivity and speciﬁcity for predicting the
presence of multiple risk factors were 91.5 cm in men and 85.5 cm
inwomen. Sensitivity and speciﬁcity were 77% (86%) and 58% (50%)
in men (women), respectively. The prevalence of MetS was esti-
mated to be approximately 27% in Tehran. The authors conclude
that the WC cut-offs recommended by the IDF are not appropriate
for use in Iran.75
The optimum BMI cut-off point for the Iranian population based
on MetS risk factors were investigated together with the BMI cut-
off points with and without waist WC as a cofactor of risk and
compared the differences, as part of the Shiraz Heart study. Sub-
jects (n¼ 12,283) were between the ages of 20e65 years old. All the
features of MetS were found in 38.9% of the sample population,
which was more prevalent among women than men (41.5% vs.
36%). The optimum BMI cut-off point for predicting MetS was
26.1 kg/m2 and 26.2 kg/m2 for males and females, respectively.abolic syndrome in Iran: A review, Translational Metabolic Syndrome
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acquiring metabolic risk factors in males decreased to 25.7 kg/m2
and increased for women to 27.05 kg/m2.90
Cross-sectional data from 3277 Iranian adults >20 years adults
living in Zanjan, in north western Iran were analysed to identify
cut-offs for WC that confer increased risk of MetS. After excluding
WC, the, existence of two or more of the remaining four risk factors
of the modiﬁed ATPIII criteria for MetS were deﬁned as multiple
risk factors. The cut-off values that had the maximal sensitivity and
speciﬁcity for predicting the presence of MetS (multiple risk fac-
tors) were 87 cm in men and 82 cm in women. Cut-offs corre-
sponding to a BMI of 25 and 30 kg/m2 to predict MetS were 84 and
97 cm in men and 78 and 91 cm in women, respectively. The au-
thors suggest that lower cut-off values forWC should be considered
in the identiﬁcation of individuals at high risk of MetS in the Iranian
population.91
There is a lack of compelling evidence that waist circumference
(WC) is a cardiovascular disease (CVD) risk factor in some ethnic
groups,92 The optimal cut-off points of WC for predicting incident
CVD and MetS was investigated in an Iranian population of 6504
participants recruited from three areas in central Iran and were
followed up for 7 years. After 394,418 person-years of follow-up,
427 incident primary CVD events (233 in men) were identiﬁed.
For CVD, the optimum cut-off points for WC were 99 and 103.5 cm
in men and women, respectively, but these had a low sensitivity
(AUC: 0.59, 95%CI 0.55e0.63 in both men and women). Using cut-
offs of 93 and 97 cm resulted in acceptable sensitivity. Regarding
MetS, 92.6 and 97.8 cmwere identiﬁed as optimum (AUC: 0.67, 95%
CI 0.65e0.69 in men and 0.65, 95%CI 0.63e0.67 in women). The
best cut-off values derived from the Cox regression model were 90
and 97 cm for men and women respectively.93
The cut-off value for WC that could be used as a surrogate index
for central obesity were also independently investigated in 907
women (mean age 34.4± 7.6 years) to determine the optimal values
for predicting IR in Iranian women of reproductive age. IR was
evaluated by the HOMA-IR and its cut off value was deﬁned as the
95th percentile of HOMA-IR value for 129 subjects, without any
metabolic abnormality. The optimal cut-off value forWC in relation
to HOMA-IR was calculated based on the receiver operating char-
acteristics (ROC) curve analysis using the Youden index and the
area under curve (AUC). After adjustment for age the odds ratios
(OR) of an elevated HOMA-IR rose with increasing WC; the age
adjusted OR of IR for women with WC > 95 cm in comparison to
those subjects with WC < 80 cm, was 9.5 (95% CI 5.6e16.1). The
optimal cut-off value for WC predicting IR was 88.5 cm; with a
sensitivity and speciﬁcity of 71% and 64%, respectively. These cut-
offs are substantially lower than were proposed in the previous
study, but may be related to the differences in age.94
8.1.2. Measures of adiposity in children
A cross-sectional survey was undertaken in a representative
sample of 14,880 school students [6640 girls (49.2%) and 75.6%
urban residents], selected by multistage random cluster sampling
from urban and rural areas of 30 provinces in Iran. Anthropometric
measures including body mass index (BMI), waist circumference
(WC), hip circumference (HC), and wrist circumference were
measured under standard protocols by using calibrated in-
struments. Age-and gender- speciﬁc reference values were deter-
mined for anthropometric measures by the maximum penalized
likelihood approach. Participants' mean age was 12.47 ± 3.36
years.95
The development of age- and gender-speciﬁc reference curves
for waist and hip circumferences was undertaken using a cross-
sectional population survey in 2003e04 and a nationally repre-
sentative sample of 21,111 school-students living in urban (84.6%)Please cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Meta
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001and rural (15.4%) areas of 23 provinces in Iran. Smoothed reference
curves for waist and hip circumference (WC, HiC) and waist-to-hip
ratio (WHR) were developed by the LMS method. WC and HiC
percentile values increased with age. For girls, the 50th to 95th
percentile curves for WC increased sharply between 8e13 years
and 11e15 years, respectively, and began to plateau after this age,
whereas in boys, these curves had a persistent and less sharp in-
crease with age, until the age of 18 years. The WHR curves of girls
decreased with age until 15 years and began to plateau thereafter,
whereas for boys the 25th to 95th curves had a plateau pattern.
Comparisons of the current reference curves with the British curves
showed that in boys, the 5th and 50th percentile curves were
similar, but the 95th percentile curve of in Iranwere higher than for
the British students. For girls, the 5th percentile curves of both
studies were similar, but the 50th and 95th percentile curves of our
study were higher than the British curves.96
The prevalence of obesity and overweight in children for
different age categories was determined using three standard
deﬁnitions of obesity. Studies have reported the prevalence of
obesity or overweight of children <6, 6e12, and 12e20 years old.
The reported prevalence of the overweight and obesity with regard
to age and gender, and also by the different standard references
which are the Centers for Disease Control and Prevention (CDC), the
World Health Organization (WHO) deﬁnition, and the International
Obesity Task Force (IOTF) references were combined. Meta-
regression analysis showed that the prevalence of obesity and
overweight did not vary signiﬁcantly by gender and age categories,
but using the different deﬁnitions led to different estimates of the
prevalence of overweight and obesity.97
The determinants of overweight and obesity were investigated
among 6635 children (3551 boys and 3084 girls, 6e11-year-old)
attending elementary school in Rasht. Data on weekly frequency of
skipping breakfast, physical activity and hours of television viewing
were collected. Information on birth weight, parental age, parental
educational levels, parental weight and height, and mother's
employment status were gathered through self- administrated
questionnaires given to the parents. The overall prevalence of
overweight was 11-5% and 15.0% for boys and girls, respectively;
while the overall prevalence of obesity was 5.0% and 5.9% respec-
tively. Children with more educated mothers had a higher preva-
lence of overweight than children with less educated mothers.
Logistic regression analysis showed that children with overweight/
obese parents, children with more educated mothers and children
who often skipped breakfast were more prone to overweight and
obesity.988.2. Estimates of insulin resistance
The optimal cut-off for the HOMA of insulin resistance for the
diagnosis of IR and MetS in non-diabetic residents of Tehran has
been reported. Optimal national cut-offs were determined for the
Iranian population for those with and without diabetes mellitus,
using data from the third National SuRFNCD. 3071 adult Iranian
individuals aged 25e64 years were analysed. MetS was deﬁned
according to the ATPIII and IDF criteria. HOMA-IR cut-offs from the
50th to the 95th percentile were calculated and sensitivity, speci-
ﬁcity, and positive likelihood ratio for MetS diagnosis were deter-
mined. The area under the curve (AUC) (95%CI) was 0.650
(0.631e0.670) for IDF-deﬁned MetS and 0.683 (0.664e0.703) with
the ATPIII deﬁnition. The optimal HOMA-IR cut-off for the diagnosis
of IDF- and ATPIII-deﬁned MetS in non-diabetic individuals was
1.775. The optimal cut-offs in diabetic individuals were 3.875
(sensitivity: 49.7%, speciﬁcity: 69.6%) and 4.325 (sensitivity: 45.4%,
speciﬁcity: 69.0%) for ATPIII- and IDF-deﬁned MetS, respectively.99bolic syndrome in Iran: A review, Translational Metabolic Syndrome
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assessed in a sample of Iranians and the associations of IR with
MetS was investigated. A total of 1327 non-diabetic and non-
hypertensive subjects (438 men, 838 women; aged 20e77 years)
were recruited from four different locations in Tehran from 2005 to
2008. The lower limit of the top quintile of HOMAvalues in subjects
without any metabolic abnormality was considered as the
threshold for IR. This threshold was 1.7 in men and 1.8 in women.
Overall, 41.1% of subjects (36.3% men; 41.5% women) had IR. The
HOMA cut-off to determine MetS was 1.95 using the ATPIII deﬁ-
nition, and 1.85 for IDF deﬁnition of MetS. IR was associated with
MetS using either deﬁnition. The sensitivity of MetS to detect IR
was 22.4% for IDF and 36.2% for ATPIII criteria. In multivariate
models, HOMAwas predicted by WC, and was inversely associated
with age and serum HDL-C. The cut point for the HOMA to detect IR
was lower than reported for other populations. The authors
conclude that IR is a robust correlate of MetS; but deﬁnitions of
MetS are insensitive measures of IR in the Iranian population.100
Non-alcoholic fatty liver disease (NAFLD) is characterised by
intrahepatic fat accumulation, IR and serum liver enzyme abnor-
malities in individuals with obesity and MetS.101 The optimal cut-
off points for HOMA-IR and QUICKI in the diagnosis of MetS and
NAFLD, using baseline data of 5511 subjects aged 18 years from a
cohort study recruited in northern Iran. The optimal cut-off points
for HOMA-IR in the diagnosis of MetS and NAFLD were 2.0 and 1.79
in men and were 2.5 and 1.95 in women, respectively. The optimal
cut off points for QUICKI in the diagnosis of MetS and NAFLD were
0.343 and 0.347 in men and were 0.331 and 0.333 in women,
respectively.102
The prevalence of NAFLD and its associated metabolic abnor-
malities were investigated in 966 school-aged children and ado-
lescents aged 7e18 years in Iran. Anthropometric and laboratory
measurement and abdominal ultrasonography for liver echoge-
nicity and size were undertaken in all subjects. A questionnaire was
also used to obtain information on demographical and medical
history, dietary habit, alcohol consumption and cigarette smoking.
Fatty liver was diagnosed by ultrasound in 7.1% of children. NAFLD
was signiﬁcantly associated with increasing age, alanine amino-
transferase (ALT), fasting insulin, total- and LDL-cholesterol, tri-
glycerides and IR. In multiple logistic regression analysis, serum
ALT, total cholesterol and WC were independent metabolic factors
predictive of NAFLD after adjustment for other variables. There was
a strong relationship between NAFLD and the abnormal metabolic
variables in children.103
A cross-sectional study aimed to determine the prevalence of
the MetS, abnormalities of liver enzymes and sonographic fatty
liver, as well as the inter-related associations in normal weight,
overweight and obese children and adolescents. A sample of 1107
students (56.1% girls), aged 6e18 years were recruited from Isfa-
han. Liver sonography was performed among 931 participants.
These variables were compared among participants with different
BMI categories. From lower to higher BMI category, ALT, total
cholesterol, LDL-C, triglycerides and SBP increased incrementally,
and HDL-C decreased signiﬁcantly. Elevated ALT, aspartate
aminotransferase (AST) and alkaline phosphatase (ALP) were
present in 4.1%, 6.6% and 9.8%, respectively of the normal weight
group. The corresponding values were 9.5%, 9.8% and 9.1% in the
overweight group, and 16.9%, 14.9% and 10.8% in the obese group.
For all BMI categories, ALT increased signiﬁcantly with an
increasing number of components of the MetS. The odds ratio for
elevated liver enzymes and sonographic fatty liver increased
signiﬁcantly with a greater number of the components of the
MetS and higher BMI categories before and after adjustment for
age.104Please cite this article in press as: Ferns GAA, Ghayour-Mobarhan M, Met
Research (2018), https://doi.org/10.1016/j.tmsr.2018.04.001The prevalence of fatty liver in obese Iranian children and its
association with MetS and IR was investigated in 102 obese Iranian
children, referred to pediatric clinics from 2011 to 2012. The eval-
uation of fatty liver was made by a pediatric endocrinologist, a pe-
diatric gastroenterologist and an expert radiologist. The grade of
fatty liver was higher in older children (P ¼ 0.001). It was also
greater in taller and heavier children (P< 0.000), and those inwhom
the BMI was greater (P ¼ 0.002). Severity of fatty liver according to
liver sonographywas positively relatedwithWC, hip circumference,
serum TG, serum FBG, serum fasting insulin, serum ALT, SBP and
HOMA index and negatively related with the level of ALP.105
The prevalence and causes of elevated ALT levels were deter-
mined among apparently healthy Iranian blood donors in Tehran. A
total of 1959 (1465 male) were randomly selected among blood
donors. BMI, viral markers and ALT levels were measured. If ALT
was elevated (>40 U/L), it was rechecked twice within 6 months.
Individuals with2 times elevated ALT levels (persistently elevated
ALT) were invited for further evaluation. Fifty-two persons (2.65%)
were found to have persistently elevated serum ALT. Among these
subjects, non-alcoholic steato-hepatitis (NASH) was diagnosed in
46 (88.4%), chronic hepatitis C virus (HCV) infection in four (7.7%),
alcoholic liver disease in one (1.92%), and drug-induced liver dis-
ease in one (1.92%). The prevalence of NASH and HCV infection in
the studied population was 2.35% and 0.4%, respectively. The mean
BMI of individuals with NASH was 30.58 kg/m2, compared with
27.28 kg/m2 of those without NASH (P < 0.001).106
To determine the homeostasis model assessment (HOMA-IR)
cut off values to identify IR and MetS in Qazvin, in central Iran, 480
men and 502 women aged 20e72 years old were recruited to this
cross-sectional study from September 2010 to April 2011. The
criteria used to deﬁneMetSwere the ATPIII, IDF and new JIS criteria.
The lower limit of the top quintile of HOMA values in normal
subjects was considered as the threshold of IR. The threshold of
HOMA for IR was 2.48. Fifty one percent of the subjects were IR
using this cut-off. The cut points for diagnosis of JIS, IDF, ATP III and
Persian IDF deﬁned MetS were 2.92, 2.91, 2.49 and 3.21,
respectively.107
9. Prospective cohort studies
A study was designed to investigate the prevalence and trends
of MetS and its components in a cohort of Iranian adults (n¼ 6500)
aged 35 years from 2001 to 2013. Subjects were randomly
selected from three provinces in central Iran. Socio-demographic
characteristics, anthropometry, blood pressure, and various
biochemical indices were collected in 2001, 2007, and 2013. Secular
trend and age-adjusted trend of MetS and its components were
calculated over the period 2001e2013. The standardized preva-
lence of MetS, hypertension, low HDL-C, central obesity, and dia-
betes/impaired glucose tolerance (IGT) increased over the 12 years
by 6.9%, 5.5%, 12.0%, 2.3%, and 18.7%, respectively, while the prev-
alence of hypertriglyceridemia decreased by 15.5%. The prevalence
of MetS, low HDL-C, and central obesity were higher in females
than males. The increasing prevalence of these metabolic abnor-
malities was higher in the rural population than in the urban
population.108
The prevalence of MetS and its individual components was
determined within the Iranian adult population in 2011 and the
changes occurring between 2007 and 2011 was assessed. Datawere
from two rounds of the Surveillance of Risk Factors of Non-
communicable Diseases national surveys conducted in 2007 and
2011. MetS was deﬁned according to IDF criteria. In 2007, the
prevalence of MetS among adults aged 25e64 years was 35.95%,
which decreased to 32.96% in 2011. Despite this overall decline, theabolic syndrome in Iran: A review, Translational Metabolic Syndrome
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HDL-C have remained constant. There was a trend towards a
decline in the proportion of individuals with increased blood
pressure, and the proportion of adults with increased fasting
plasma glucose (FPG) increased. In 2011, the prevalence of central
obesity, raised triglycerides, reduced HDL-C, increased blood
pressure and increased FPG was 51.88, 36.99%, 54.72% 38.92%, and
24.97% respectively. Between 2007 and 11, the prevalence of MetS
was reported to have fallen slightly in Iran, although the prevalence
of increased FPG has increased signiﬁcantly.109
Some recent studies have shown a stability or declining trend in
obesity in the Iranian population, while others still report
increasing trends. The trends in general and abdominal obesity
have been assessed in adults living in Tehran over a median follow-
up period of 10 years. Data from participants in the four phases of
the TLGS from 1999 to 2011 (n ¼ 10,368), aged 20 years were
analysed. The crude prevalence of general obesity and central
obesity increased from 23.1% to 47.9% at baseline, to 34.1% and 71.1%
at the end of follow-up period, respectively. Risks of obesity and
central obesity increased over the whole study period for men and
women. These rising trends were observed in all sub-groups
regardless of age, marital status and educational level.110
The incidence of MetS and its most powerful components as
predictors of MetS were investigated in a cohort study in central
Iran. 2000 participants aged 20e74 years were initially selected
using multistage random cluster sampling method from urban
areas of Yazd in 2005 and re-investigated in 2015.MetSwas deﬁned
using a modiﬁed version of the ATPIII deﬁnition.111 The prevalence
of MetS was 44.8% at baseline. Subjects without MetS were fol-
lowed up in 2015. At this time, MetS had developed in 56.1% of
these subjects. Incidence of MetS in males and females was 56.1/
1000 person-years and 58.7/1000 person-years, respectively. The
incidence of MetS increased with age and higher socio-economic
status and decreased with increasing level of education. In fe-
males and males the most powerful component for incidence of
MetS was a high FBG (HR ¼ 16.6, 95% CI: 1.91e22.82) and hyper-
triglyceridemia (HR ¼ 1.64, 95% CI: 1.02e2.6), respectively.112
10. Conclusions
MetS is a common condition in Iran, with a higher prevalence in
women. Whilst the prevalence of several of the components of the
MetS appears to be rising, it is unclear whether this is also true for
the MetS as deﬁned by several criteria. There is a signiﬁcant vari-
ation in the prevalence of MetS by region and ethnicity, and this is
likely to be multifactorial, with socioeconomic status and diet
playing an important role.
The features of MetS develop early in adolescence and may be
detected using simple anthropometric measurements. However
the precise cut-off values for these need to be agreed nationally and
applied to population screening. This would be worthwhile, as
lifestyle interventions appear to be effective.
Unravelling the genetics and proteomics of the MetS is likely to
be complex,114e116 andwill rely on an international consensus on its
phenotype, if large multinational studies are to be feasible.
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